Clinical Trial Update: A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the effects of renal impairment on the pharmacokinetics and tolerability of eliglustat tartrate in Gaucher disease. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Cerdelga (Eliglustat)

Snippet

Sponsor: Sanofi | Conditions: Gaucher Disease | Phase 1 | Status: COMPLETED